πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 980 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7691885

Pyridones useful as inhibitors of kinases

Vertex Pharmaceuticals Incorporated Β· Granted Tue Apr 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7691902

Modulators of ATP-binding cassette transporters

Vertex Pharmaceuticals Incorporated Β· Granted Tue Apr 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7691853

Pyrazole compounds useful as protein kinase inhibitors

Vertex Pharmaceuticals Incorporated Β· Granted Tue Apr 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7683083

Biphenyl derivatives as modulators of voltage gated ion channels

Vertex Pharmaceuticals Incorporated Β· Granted Tue Mar 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7683065

Pyridines useful as modulators of ion channels

Vertex Pharmaceuticals Incorporated Β· Granted Tue Mar 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7683066

Isoquinolines useful as modulators of ion channels

Vertex Pharmaceuticals Incorporated Β· Granted Tue Mar 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7683033

Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

Vertex Pharmaceuticals Incorporated Β· Granted Tue Mar 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7678802

Quinazolines useful as modulators of ion channels

Vertex Pharmaceuticals Incorporated Β· Granted Tue Mar 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7671221

Modulators of ATP-Binding Cassette transporters

Vertex Pharmaceuticals Incorporated Β· Granted Tue Mar 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7666647

Inhibitors of GSK-3 and crystal structures of GSK-3Ξ² protein and protein complexes

Vertex Pharmaceuticals Incorporated Β· Granted Tue Feb 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7659268

Modulators of ATP-binding cassette transporters

Vertex Pharmaceuticals Incorporated Β· Granted Tue Feb 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7659309

Polymorphic forms of (1-{3-[3-(4-cyano-3-methoxy-phenyl) ureido]-phenyl}-ethyl)-carbamic a

Vertex Pharmaceuticals Incorporated Β· Granted Tue Feb 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7659283

Pyrrolo [3,2-C] pyridines useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated Β· Granted Tue Feb 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7652153

Caspase inhibitors and uses thereof

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jan 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7652135

Compositions useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jan 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7645789

Indole derivatives as CFTR modulators

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jan 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7645775

Triazoles useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jan 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7625913

Pyrazole compounds useful as protein kinase inhibitors

Vertex Pharmaceuticals Incorporated Β· Granted Tue Dec 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7622463

Dihydrodiazepines useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated Β· Granted Tue Nov 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7612091

Caspase inhibitors and uses thereof

Vertex Pharmaceuticals Incorporated Β· Granted Tue Nov 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7612065

Inhibitors of c-JUN N-terminal kinases (JNK)

Vertex Pharmaceuticals Incorporated Β· Granted Tue Nov 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7608632

Sulfonamide inhibitors of aspartyl protease

Vertex Pharmaceuticals Incorporated Β· Granted Tue Oct 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7605270

Polymorphic forms of (S).-tetrahydrofuran-3-yl-3-(3-(3-methoxy-4-(oxazol-5-yl) phenyl) ure

Vertex Pharmaceuticals Incorporated Β· Granted Tue Oct 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7605174

Indane derivatives as modulators of ion channels

Vertex Pharmaceuticals Incorporated Β· Granted Tue Oct 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted